Literature DB >> 14999607

Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex.

Kelly Wilber Quispe Tintaya1, Xu Ying, Jean-Pierre Dedet, Suman Rijal, Xavier De Bolle, Jean-Claude Dujardin.   

Abstract

BACKGROUND: Efficient monitoring of endemic and resurgent visceral leishmaniasis (VL) requires discriminatory molecular tools that allow direct characterization of etiological agents (i.e., the Leishmania donovani complex) in host tissues. This characterization is possible through restriction fragment-length polymorphism (RFLP) analysis of polymerase chain reaction (PCR)-amplified sequences (PCR-RFLP).
METHODS: We present 2 new PCR-RFLP assays that target the gene locus of cysteine proteinase B (cpb), an important Leishmania antigen. The assays were applied to the characterization of 15 reference strains of the L. donovani complex, and their discriminatory power was compared with that of PCR-RFLP analysis of the gp63 gene, another Leishmania antigen, and with that of multilocus enzyme electrophoresis (MLEE), which is the reference standard for parasite typing.
RESULTS: Restriction patterns of the cpb locus were polymorphic, but less so than gp63 patterns. When data for both loci were combined, differences between PCR-RFLP and MLEE results were encountered. Antigen gene analysis was more discriminatory and supported a different classification of parasites, one that fitted with their geographic origin. PCR-RFLP analysis of cpb also allowed direct genotyping of parasites in bone marrow aspirate and venous blood samples obtained from patients with VL.
CONCLUSION: Antigen genes constitute valid targets for PCR-based Leishmania typing without the need for isolation of parasites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999607     DOI: 10.1086/382049

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

2.  Heterogeneity of Leishmania infantum chagasi kinetoplast DNA in Teresina (Brazil).

Authors:  Diego Peres Alonso; Dorcas Lamounier Costa; Ivete Lopes de Mendonça; Carlos Henrique Nery Costa; Paulo Eduardo Martins Ribolla
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum.

Authors:  S Hendrickx; G Boulet; A Mondelaers; J C Dujardin; S Rijal; L Lachaud; P Cos; P Delputte; L Maes
Journal:  Parasitol Res       Date:  2014-03-11       Impact factor: 2.289

4.  Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic.

Authors:  Pankaj Srivastava; Vijay Kumar Prajapati; Madhukar Rai; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

5.  Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal.

Authors:  Saskia Decuypere; Suman Rijal; Vanessa Yardley; Simonne De Doncker; Thierry Laurent; Basudha Khanal; François Chappuis; Jean-Claude Dujardin
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.

Authors:  Tim Downing; Hideo Imamura; Saskia Decuypere; Taane G Clark; Graham H Coombs; James A Cotton; James D Hilley; Simonne de Doncker; Ilse Maes; Jeremy C Mottram; Mike A Quail; Suman Rijal; Mandy Sanders; Gabriele Schönian; Olivia Stark; Shyam Sundar; Manu Vanaerschot; Christiane Hertz-Fowler; Jean-Claude Dujardin; Matthew Berriman
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

7.  Genetic heterogeneity in clinical isolates of Leishmania donovani from India.

Authors:  Pankaj Srivastava; Toolika Singh; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

8.  Detection and identification of Leishmania species from clinical specimens by using a real-time PCR assay and sequencing of the cytochrome B gene.

Authors:  Françoise Foulet; Françoise Botterel; Pierre Buffet; Gloria Morizot; Danièle Rivollet; Michèle Deniau; Francine Pratlong; Jean-Marc Costa; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

9.  Linking in vitro and in vivo survival of clinical Leishmania donovani strains.

Authors:  Manu Vanaerschot; Ilse Maes; Meriem Ouakad; Vanessa Adaui; Louis Maes; Simonne De Doncker; Suman Rijal; François Chappuis; Jean-Claude Dujardin; Saskia Decuypere
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

10.  Metabolomics to unveil and understand phenotypic diversity between pathogen populations.

Authors:  Ruben t'Kindt; Richard A Scheltema; Andris Jankevics; Kirstyn Brunker; Suman Rijal; Jean-Claude Dujardin; Rainer Breitling; David G Watson; Graham H Coombs; Saskia Decuypere
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.